BK virus (BKV) was isolated from a renal allograft recipient with stenosis of the transplanted ureter. 1 Initial concerns of BKV infection were focused on this complication. 2 Interest in BKV later shifted to its role in haemorrhagic cystitis (HC) after haematopoietic SCT, 3 and in polyomavirus-associated nephropathy (PVAN) after renal allografting. 4 An important difference exists between the two: high levels of BKV viraemia are found in PVAN but not in HC post HSCT, where only high levels of BKV viruria are found. 4, 5 A 20-year-old man underwent HSCT from a matched unrelated donor for AML. Conditioning consisted of BU (800 mg), CY (6.2 gm) and rabbit antithymocyte globulin (325 mg). GVHD prophylaxis included ciclosporin and mycophenolate mofetil. There was no evidence of acute GVHD. Neutrophil engraftment occurred on day 10 post HSCT. HC developed 1 month post HSCT, which was confirmed by polyomavirus on urinary EM. There was no response to bladder irrigation, corticosteroids and ciprofloxacin. 6 A week later, his renal function deteriorated, despite cessation of ciclosporin (Figure 1a) . A computed tomography scan showed bilateral hydronephrosis and hydroureters at the vesicoureteric junction (Figure 1b) , which was confirmed by retrograde pyelogram (Figure 1c) . Bilateral double-J stents were inserted. Although renal function normalized, HC continued. A month later, renal function deteriorated. Another retrograde pyelogram showed that the previously dilated ureters were instead stenosed up to the renal pelvis (Figure 1d ). Bilateral percutaneous nephrostomy was performed, leading to normalization of renal function.
These unusual features prompted measurement of blood and urinary BKV by quantitative PCR). 5 The initial urinary BKV level was 1.2 Â 10 8 copies/mL (Figure 1a ), within the range in HC post HSCT.
5 Unexpectedly, the plasma BKV level was elevated to 4.6 Â 10 6 copies/mL, about 3-log more than the expected level post HSCT with or without HC, 5 but in the range of PVAN with our quantitative PCR. 7 Because of high BKV viraemia, immunosuppression was reduced as in PVAN. Mycophenolate mofetil was withdrawn, resulting in a decline of BKV viraemia and viruria. An antegrade pyelogram 2 weeks later showed correspondingly a significant improvement of ureteric stenosis (Figure 1e ).
Six weeks after cessation of immunosuppression , there was a 2-3-log decrease in BKV viraemia and viruria. To enhance BKV clearance, i.v. cidofovir (0.5 mg/kg/week Â 4) was administered. By the third dose of cidofovir, the patient's HC had subsided and percutaneous nephrostomy was taken off. Eight months post HSCT, the patient was asymptomatic with normal renal function, and BKV viraemia and viruria were at levels expected of otherwise asymptomatic HSCT patients. 5, 6 The uniqueness of this case is best appreciated by first considering two different patterns of BKV-associated diseases. HC post HSCT is related to uncontrolled uroepithelial BKV replication during the initial immunosuppression post HSCT. 8 Upon immune regeneration, BKV-laden uroepithelial cells become the target of immunocompetent cells, similar to other immunereconstitution diseases. 8 Cellular destruction results from immune attack and not viral-mediated lysis, so virus release into the circulation is minimal. As HC is found virtually only after allogeneic HSCT, it may be regarded as localized acute GVHD. 9 Therefore, increased immunosuppression may be useful. 9 In PVAN, however, high levels of BK viraemia are observed. 8 Renal damage is due to the direct cytopathic effects of BKV. Viralmediated cell lysis therefore leads to viraemia. Because of antirejection immunosuppression, host immune response is limited. Therefore, PVAN represents a cytopathic inflammatory pattern of BKV-associated disease. 8 Contrary to HC post HSCT, decrease in immunosuppression is required.
This case is exceptional in that it provides a link between the pathogenetic mechanisms of HC and PVAN. The initial clinical features of HC were consistent with the immune-reconstitution pattern. 8 However, subsequent investigations showed high BKV viraemia. This was very unusual, because in more than 100 HSCT patients serially monitored by quantitative PCR only low or nonquantifiable BKV viraemia was detected. 5, 6, 10, 11 Therefore, virological features also suggested the cytopathic inflammatory pattern as in PVAN. 8 Furthermore, the conditioning contained rabbit antithymocyte globulin, an independent risk factor for BKV reactivation after renal allografting. 12 Initial stenosis occurred at the vesicoureteric junction, the site typically affected after renal allografting. Ultimately, the whole ureter was stenosed. As renal function normalized after relief of the obstruction, renal parenchymal damage if any was insignificant, suggesting that viral damage was limited to the ureters and bladder.
Ureteric infection by BKV had been demonstrated in resected allograft kidneys. 2 In a descriptive study, obstructive uropathy due to ureteric stenosis secondary to BKV-associated HC had also been reported. 12 Therefore, ureteric stenosis appears to be also a problem, albeit rare, post HSCT.
Finally, definition of viral kinetics was crucial to successful management of the disease. In HC post HSCT, increase in immunosuppression is often beneficial. 9 However, demonstration of high levels of BKV viraemia led instead to a reduction in immunosuppression as in PVAN, 8 resulting in decreases in BKV viraemia and viruria and a corresponding recovery of ureteric stenosis.
